Skip to main content

ORIGINAL RESEARCH article

Front. Genet.
Sec. Genetics of Common and Rare Diseases
Volume 16 - 2025 | doi: 10.3389/fgene.2025.1531697

Clinical phenotype and genetic analysis of patients with severe oligoasthenospermia carrying heterozygous SOHLH1 c.346-1G>A mutation

Provisionally accepted
Xiaojun Wen Xiaojun Wen 1Zhiming Li Zhiming Li 1Lizi Cheng Lizi Cheng 1*Jianhong Wei Jianhong Wei 1*Wenjuan Yu Wenjuan Yu 1*Xiufeng Lin Xiufeng Lin 1,2*Xiaowu Fang Xiaowu Fang 1*
  • 1 Reproductive Medicine Center, Boai Hospital of Zhongshan, Zhongshan, China
  • 2 The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China

The final, formatted version of the article will be published soon.

    Severe oligoasthenospermia (SOA) is a prevalent cause of male infertility. However, the underlying causes of most SOA cases remain unclear due to the complexity of germ cell development and the significant genetic heterogeneity associated with male infertility. Therefore, in this study, we aimed to elucidate the genetic etiology of two cases of male infertility resulting from SOA and clarify the novel clinical phenotype associated with a heterozygous mutation at the c.346-1G>A site of the SOHLH1 gene. Through whole-exome sequencing, we found that patients with SOA carried heterozygous mutations at the c.346-1G>A site. This variant is classified as pathogenic based on disease database records and literature reports. Notably, our study demonstrated that patients with heterozygous mutations at the c.346-1G>A site exhibited severely reduced sperm counts, significantly impaired sperm motility, and pronounced morphological deformities. One patient underwent assisted reproductive treatment through an intracytoplasmic sperm injection and achieved a favorable outcome, resulting in a successful pregnancy. In conclusion, our study provides the first evidence that the heterozygous mutation at the c.346-1G>A site of SOHLH1 is associated with SOA, and elucidates the new clinical phenotype associated with this mutation.

    Keywords: male infertility, SOA, SOHLH1 gene, Novel clinical phenotype, Intracytoplasmic sperm injection

    Received: 20 Nov 2024; Accepted: 13 Jan 2025.

    Copyright: © 2025 Wen, Li, Cheng, Wei, Yu, Lin and Fang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Lizi Cheng, Reproductive Medicine Center, Boai Hospital of Zhongshan, Zhongshan, China
    Jianhong Wei, Reproductive Medicine Center, Boai Hospital of Zhongshan, Zhongshan, China
    Wenjuan Yu, Reproductive Medicine Center, Boai Hospital of Zhongshan, Zhongshan, China
    Xiufeng Lin, Reproductive Medicine Center, Boai Hospital of Zhongshan, Zhongshan, China
    Xiaowu Fang, Reproductive Medicine Center, Boai Hospital of Zhongshan, Zhongshan, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.